Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer, May 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 224 articles: HTML format

Single Articles

1. KAWIA H, Mgaya J, Paul L
   Linamarin and its analogues as targeted therapeutic agents in cervical cancer: insights from atomistic molecular docking, dynamics and MMPBSA calculations.
   In Silico Pharmacol. 2026;14:132.
   PubMed    
   Abstract available
   
   

2. ABDULLAH H, Mamat N, Sazeli S, Hapidin H, et al
   Upregulation of Apoptotic Protein and Migration-Inhibitory Effects of Gallic Acid and Methyl Gallate Combined with Cisplatin in HeLa Cervical Cancer Cells.
   Trop Life Sci Res. 2026;37:109-131.
   PubMed    
   Abstract available
   
   

3. PHISALMONHKHON T, Kantathavorn N, Wetcho T, Samrarn J, et al
   Long-Term Survival Outcomes of HPV DNA-Negative Cervical Cancer Compared with HPV DNA-Positive Disease in a Thai Tertiary Cohort.
   Int J Womens Health. 2026;18:601452.
   PubMed    
   Abstract available
   
   

4. BADWAN SN, McKinnish TR, Massad LS, Markovina S, et al
   Correlation of patient reported outcomes and physical exam screening for pelvic floor dysfunction: An opportunity for improved quality of life during chemoradiotherapy for cervical cancer.
   Gynecol Oncol Rep. 2026;65:102083.
   PubMed    
   Abstract available
   
   

5. WANG Y, Tang N, Zhang W, Zeng Y, et al
   An interpretable machine learning model for predicting symptomatic pelvic lymphocele after pelvic lymphadenectomy in cervical cancer.
   Front Oncol. 2026;16:1754363.
   PubMed    
   Abstract available
   
   

6. AGU PU, Dim CC, Nnagbo JE, Odoh GU, et al
   Awareness of cervical cancer prevention among rural dwellers in Enugu State, Nigeria: findings from Ituku outreach.
   Rural Remote Health. 2026;26:10083.
   PubMed    
   Abstract available
   
   

7. ZHANG T, Yu Y, Zhang C, Zhang M, et al
   Multi-omics analysis reveals the alterations in the tumor microbiome and metabolome associated with cervical cancer lymph node metastasis.
   Microbiol Spectr. 2026 Apr 30:e0224725. doi: 10.1128/spectrum.02247.
   PubMed    
   Abstract available
   
   

8. LEE CY, Wang PH, Hsieh YH, Hsiao YH, et al
   GO-Y078 Triggers Program Cell Death in Human Cervical Cancer Cells Via MAPK Activation-Dependent Apoptotic Caspases Signaling.
   Integr Cancer Ther. 2026;25:15347354251411859.
   PubMed    
   Abstract available
   
   

9. HERNANDEZ S, Ahuja A, Kakkad N, Nignang CT, et al
   "My Wife's Healthcare Is my Healthcare": A Qualitative Study Exploring Family-Centered Strategies to Enhance Cervical Cancer Prevention in Northern Ghana.
   Cancer Control. 2026;33:10732748261448259.
   PubMed    
   Abstract available
   
   

10. SLESNICK LD, Gordy E, Class QA, Gokhale P, et al
    Follow-Up Cervical Cancer Screening After Benign and Low-Grade Colposcopy.
    AJPM Focus. 2025;5:100425.
    PubMed    
    Abstract available
    
    

11. JIANG Y, Cui Y, Su D, Yang H, et al
    Immune checkpoint inhibitor-associated diabetic ketoacidosis induced by cadonilimab: a case report and literature review.
    Front Endocrinol (Lausanne). 2026;17:1819809.
    PubMed    
    Abstract available
    
    

12. XU Z, Zhang L, Wang H, Li X, et al
    Combined neutrophil-to-lymphocyte ratio and nomogram for predicting progression-free survival in recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors.
    Front Immunol. 2026;17:1811428.
    PubMed    
    Abstract available
    
    

13. WANG S, Xiao H, Gao H
    A novel methylation marker on the CLEC14A gene for cervical cancer screening.
    Front Oncol. 2026;16:1730952.
    PubMed    
    Abstract available
    
    

14. MATHIBELA SP, Lebelo MT, Steenkamp V
    Antiproliferative Effects of Cannabinoids and Cisplatin in Cervical Cancer Cells.
    Cancer Rep (Hoboken). 2026;9:e70561.
    PubMed    
    Abstract available
    
    

15. CALDERON AM, Goyal S, Peddinani B, Lopez M, et al
    EPR26-154: Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data.
    J Natl Compr Canc Netw. 2026;24.
    PubMed    
    
    
    

16. BONI S, Goore D, Adie M, Gnahatin F, et al
    Cervical Cancer Screening Cascade in Cote d'Ivoire: A Decade of Real-World Program Evaluation According to HIV Status.
    JCO Glob Oncol. 2026;12:e2500164.
    PubMed    
    Abstract available
    
    

17. GUPTA RD, Sarker P, Haider SS, Mazumder A, et al
    Determinants and Socioeconomic Inequalities in Breast and Cervical Cancer Screening in Tajikistan: Evidence From the 2023 Demographic and Health Survey.
    JCO Glob Oncol. 2026;12:e2500582.
    PubMed    
    Abstract available
    
    

18. ORTIZ AP, Ramos-Cartagena JM, Torres-Cintron CR, Santiago-Rodriguez EJ, et al
    Age Differences in Hysterectomy-Corrected Cervical Cancer Incidence Trends in Puerto Rico, 2001-2023.
    JAMA Netw Open. 2026;9:e269681.
    PubMed    
    
    
    

19. SHEN F, Chen J, Gu Y, Li Y, et al
    Cervical cancer derived extracellular vesicles expressed higher level of CD24 and suppressed the phagocytosis of macrophages.
    Discov Oncol. 2026 Apr 29. doi: 10.1007/s12672-026-05124.
    PubMed    
    Abstract available
    
    

20. HUANG M, Gong C, Liu B, Wang Y, et al
    Exploration of overlap volumes-based IMRT Rapidplan for cervical cancer patients with the aim of OARs sparing.
    Phys Eng Sci Med. 2026 Apr 29. doi: 10.1007/s13246-026-01732.
    PubMed    
    
    
    

21. DERIBE KS, Shewaye S, Wondimagegnehu A, Azmera YM, et al
    Unmet palliative care needs and determinants among women with breast and cervical cancer and their caregivers in Ethiopia.
    Front Oncol. 2026;16:1788481.
    PubMed    
    Abstract available
    
    

22. MUTYABA I, Akurut H, Nabaasa R, Limo J, et al
    Facilitators and Barriers to Cervical Cancer Screening Among Women in a Rural District of Northeastern Uganda, a Qualitative Study.
    Cancer Manag Res. 2026;18:598738.
    PubMed    
    Abstract available
    
    

23. NEMETH BLAZIC T, Zhu Q, Cahun E, Nola IA, et al
    Developing a digital interactive tool to enhance cervical cancer awareness and health literacy in Croatia: a community case study.
    Front Public Health. 2026;14:1767197.
    PubMed    
    Abstract available
    
    

24. DING N, Chen Y, Zhou X, Wang G, et al
    Women's preferences for HPV self-sampling in cervical cancer screening: a discrete choice experiment.
    Front Public Health. 2026;14:1779443.
    PubMed    
    Abstract available
    
    

25. ZHANG Y, Zhuo Q, Abuduwufu S, Wushouer A, et al
    Dual-specificity phosphatase 14 inhibits the growth of cervical cancer cells by regulating the transforming growth factor-beta-activated kinase 1 and NOD-like receptor pyrin domain containing 3 inflammatory pathways.
    J Int Med Res. 2026;54:3000605261441200.
    PubMed    
    Abstract available
    
    

26. WANG D, Wu S, Wang H, Yan B, et al
    FAT4 restrains epithelial-mesenchymal transition and metastasis in cervical cancer and shapes the tumor immune microenvironment.
    J Transl Med. 2026 Apr 28. doi: 10.1186/s12967-026-08177.
    PubMed    
    
    
    

27. ZHU Q, Xu G, Wang T, Ding Z, et al
    Downregulation of LRRC59 suppresses cervical cancer progression likely by inhibiting YBX1-mediated Wnt/beta-catenin signaling.
    Sci Rep. 2026 Apr 28. doi: 10.1038/s41598-026-50275.
    PubMed    
    Abstract available
    
    

28. ZHAO ZY, Zheng QJ, Zhao XL, Zhao FH, et al
    [Current status of artificial intelligence applications in cervical cancer screening: a systematic review].
    Zhonghua Yi Xue Za Zhi. 2026;106:1630-1638.
    PubMed    
    Abstract available
    
    

29. GARCIA-MONTOYA IA, Picazo-Perez L, Arellano-Ortiz AL, Salcedo-Vargas M, et al
    Obesity and Pro-Inflammatory Cytokines: Gene Expression Patterns Within Cervical Cancer Progression.
    In Vivo. 2026;40:1463-1472.
    PubMed    
    Abstract available
    
    

30. KOVALYOV O, Kovalyov K, Deinichenko O, Dillner J, et al
    HPV self-sampling for cervical cancer screening during wartime: a pilot implementation study from a conflict-affected region of Ukraine.
    BMJ Glob Health. 2026;11:e023478.
    PubMed    
    Abstract available
    
    

31. KOKSAL OK, Baydemir SK, Oncu HN, Bakan FE, et al
    The Association Between the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score and Lymph Node Metastasis in Early and Locally Advanced Cervical Cancer.
    J Obstet Gynaecol Res. 2026;52:e70290.
    PubMed    
    Abstract available
    
    

32. ALVAREZ A, Diaz S, Nino RA, Medina YA, et al
    Cost-effectiveness of Including p16/Ki-67 Dual Staining in the Detection of Cervical Lesions in Colombia, 2024.
    Rev Colomb Obstet Ginecol. 2026;77.
    PubMed    
    Abstract available
    
    

33. SATOH M, Sato N
    Participation in Cervical and Breast Cancer Screening Among Working Women in Japan: Panel Survey Study.
    JMIR Cancer. 2026;12:e86885.
    PubMed    
    Abstract available
    
    

34. WANG M, Zuo C, Wang K, Li F, et al
    BA-UNet: A Boundary Augmented Segmentation Network for Cervical Cancer Radiotherapy.
    J Imaging Inform Med. 2026 Apr 28. doi: 10.1007/s10278-026-01953.
    PubMed    
    Abstract available
    
    

35. GORGATI E, Lotfi F, Boughriou M, Zendehdel K, et al
    Cervical cancer prevention in migrant women: Overcoming barriers.
    Health Care Women Int. 2026 Apr 28:1-7. doi: 10.1080/07399332.2026.2660648.
    PubMed    
    
    
    

36. ATAYA J, Alotaki B, Alhammadi K, Homsi TA, et al
    Knowledge, attitudes, and practices regarding cervical cancer screening among women in Damascus, Syria: A cross-sectional study.
    Womens Health (Lond). 2026;22:17455057261443140.
    PubMed    
    Abstract available
    
    

37. YANG Y, Zhou H, Wang Y, Zhang H, et al
    A Triage Model for HR-HPV Positive Women Based on Methylation of Human and HPV Genes.
    J Med Virol. 2026;98:e70930.
    PubMed    
    Abstract available
    
    

38. PRUSKI D, Millert-Kalinska S, Zurawski J, Jach R, et al
    The use of the HPV vaccine in a group of primarily unvaccinated HPV-positive patients.
    Hum Vaccin Immunother. 2026;22:2664310.
    PubMed    
    Abstract available
    
    

39. FRANKLIN G, Larsen P, Henry C, Johnson C, et al
    Financial Toxicity in Cervical Cancer Patients Undergoing Radical Treatment With External Beam Radiation and Brachytherapy at a Tertiary New Zealand Radiation Oncology Centre.
    J Med Imaging Radiat Oncol. 2026 Apr 28. doi: 10.1111/1754-9485.70112.
    PubMed    
    Abstract available
    
    

40. AN JE, Kim NK, Lee SH, Kim KH, et al
    Factors affecting health-related quality of life in cervical cancer survivors: a multicenter cross-sectional study in Korea.
    BMC Womens Health. 2026 Apr 27. doi: 10.1186/s12905-026-04459.
    PubMed    
    
    
    

41. WU SY, Wang DY, He JX, Wang HX, et al
    [Experimental study on the inhibitory effects of recombinant bee venom peptide on the malignant biological behavior of cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:316-327.
    PubMed    
    Abstract available
    
    

42. DENG ZP, Wu D, Lai WX, Geng LN, et al
    [Evaluating the efficiency of 24 secondary triage strategies for detecting cervical lesions of self-collected high-risk HPV-positive women].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:289-304.
    PubMed    
    Abstract available
    
    

43. CHO AR, Park SY, Sim DY, Ahn CH, et al
    Targeting the CNOT2/VEGF pathway by Cornin attenuates angiogenesis and invasion in cervical cancer cells.
    Sci Rep. 2026 Apr 27. doi: 10.1038/s41598-026-50829.
    PubMed    
    Abstract available
    
    

44. ANDREW-BASSEY UI, Bello YO, Okunlola MA, Morhason-Bello IO, et al
    Women's preferences and concerns on HPV screening sampling methods for cervical cancer in Ibadan, Nigeria: a cross-sectional study.
    BMJ Open. 2026;16:e110692.
    PubMed    
    Abstract available
    
    

45. TAGUE C, Junaid A, Anwar Y, Asad S, et al
    Human papillomavirus: role of HPV2 and HPV9 in reducing the burden of cervical cancer in sub-Saharan Africa.
    Int J Infect Dis. 2026 Apr 25:108733. doi: 10.1016/j.ijid.2026.108733.
    PubMed    
    Abstract available
    
    

46. WENDEL SO, Brooke GM, Hu C, Sandoval AR, et al
    Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer.
    Cancer Res Commun. 2026 Apr 27. doi: 10.1158/2767-9764.CRC-25-0648.
    PubMed    
    Abstract available
    
    

47. YANG N, Liu L, Ding L, Chen Z, et al
    GE11/RGD Dual-Ligand Copper Nanoassemblies Synchronize Cuproptosis and Photothermal Therapy for Targeted Cervical Cancer Ablation.
    Mol Pharm. 2026 Apr 27. doi: 10.1021/acs.molpharmaceut.6c00002.
    PubMed    
    Abstract available
    
    

48. MAO F, Cook RJ, Lorey T, Wentzensen N, et al
    Two-phase designs for cost-effective evaluation of cancer screening tests.
    Biometrics. 2026;82:ujag058.
    PubMed    
    Abstract available
    
    

49. GUNGOR SERIN B, Temiz BE, Tuncer H, Atakul MO, et al
    Association of Oral Papivir/Pavirona((R)) Supplementation with HPV DNA Clearance.
    Viruses. 2026;18:455.
    PubMed    
    Abstract available
    
    

50. KNAP-WIELGUS W, Knap A, Pietrzak B, Suchonska B, et al
    A Role of the Lower Genital Tract Microbiome in Promoting Cervical Intraepithelial Neoplasia: A Premalignant Precursor of Cervical Cancer-A Literature Review.
    Viruses. 2026;18:403.
    PubMed    
    Abstract available
    
    

51. WANG F, Zhan Q, Dai Z, Zhang H, et al
    Lattice Radiation Therapy Plays a Synergistic Role in the Radical Treatment of Bulky Cervical Cancer: A Case Report and Literature Review.
    Curr Oncol. 2026;33:196.
    PubMed    
    Abstract available
    
    

52. LU L, Chen X, Liu J, Chen G, et al
    A Lightweight Skeletal Muscle Intelligent Segmentation Network Based on Planning CT for Cervical Cancer Radiotherapy.
    Technol Cancer Res Treat. 2026;25:15330338261446535.
    PubMed    
    Abstract available
    
    

53. HULIKAL N, Panneerselvam V, Banoth M, Singaram NK, et al
    Open Versus Laparoscopic Radical Hysterectomy Using Myoma Screw for Early-Stage Cervical Cancer- A Retrospective Analysis from Pre-LACC Era.
    Indian J Surg Oncol. 2026;17:670-675.
    PubMed    
    Abstract available
    
    

54. SHU H, Wang M, Zhang L, Jiang X, et al
    Application of omental flap in total vaginectomy for post-radiotherapy recurrent cervical cancer: a case report.
    Front Surg. 2026;13:1779661.
    PubMed    
    Abstract available
    
    

55. LU S, Liu K, Luo W, Zheng S, et al
    PD-L1 expression patterns in stage IB1 cervical squamous cell carcinoma: a retrospective study on implications for tumor budding and immune microenvironment.
    PeerJ. 2026;14:e21052.
    PubMed    
    Abstract available
    
    

56. JIANG CQ, Song Z, Yan ZC, Liu Y, et al
    MXene-based CRISPR/Cas9 nanoplatform targeting FABP5 for ROS amplification and synergistic photothermal/photodynamic therapy of cervical cancer.
    J Nanobiotechnology. 2026 Apr 27. doi: 10.1186/s12951-026-04480.
    PubMed    
    Abstract available
    
    

57. SK ABD RAZAK R, Amsah N, Heng PP, Jane Ling MY, et al
    Barriers and facilitators of cervical cancer screening among female healthcare professionals: a systematic review.
    BMC Public Health. 2026 Apr 27. doi: 10.1186/s12889-026-27501.
    PubMed    
    
    
    

58. DELATTRE C, Uthuriague M, Barnetche T, Lambert M, et al
    Cervical cancer screening practices among patients with autoimmune and inflammatory rheumatic diseases: a descriptive cross-sectional observational study.
    BMC Womens Health. 2026 Apr 25. doi: 10.1186/s12905-026-04475.
    PubMed    
    
    
    

59. TANAKA YK, Yamazaki K, Yomogita N, Yamazaki S, et al
    Evaluation of Platinum Transfer to Breast Milk in Cervical Cancer Patient Undergoing Cisplatin-Based Chemotherapy.
    Biol Trace Elem Res. 2026 Apr 25. doi: 10.1007/s12011-026-05114.
    PubMed    
    
    
    

60. HE L, Liang W, Zheng Y, Wu Q, et al
    A GPU-accelerated brachytherapy planning framework for template-based applications: Evaluated on three-dimensional printed individual templates in cervical cancer.
    Brachytherapy. 2026 Apr 24:S1538-4721(26)00025.
    PubMed    
    Abstract available
    
    

61. DIAZ-PALOMERA CD, Gonzalez-Lucano LR, Garcia-Bernal JR, de Arellano-Sanchez JAR, et al
    Modulatory effects of Pioglitazone on the CAF-driven malignant phenotype in cervical cancer: an in vitro bidirectional study.
    Discov Oncol. 2026 Apr 25. doi: 10.1007/s12672-026-04898.
    PubMed    
    
    
    

62. YAN Y, Li J, Zhang C, Yang R, et al
    miR-1247-5p is correlated with cervical cancer and regulates cervical cancer cell functions by targeting DVL1.
    Nucleosides Nucleotides Nucleic Acids. 2026.
    PubMed    
    Abstract available
    
    

63. YILMAZ E, Murray GL, Balgovind P, Garland SM, et al
    International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening.
    J Med Virol. 2026;98:e70936.
    PubMed    
    Abstract available
    
    

64. TAO H, Tong Z, Li H, Mao S, et al
    Paired box 1 gene methylation as a promising triage strategy for atypical squamous cells: a retrospective comparison with high-risk HPV testing in cervical cancer screening.
    Infect Agent Cancer. 2026 Apr 24. doi: 10.1186/s13027-026-00763.
    PubMed    
    Abstract available
    
    

65. MENGISTIE MB, Mengstie SK, Teferi GH, Shume AW, et al
    Predicting cervical cancer among women living with HIV/AIDS at public health facilities in a resource-limited setting in Ethiopia using machine learning analysis.
    Discov Oncol. 2026 Apr 24. doi: 10.1007/s12672-026-05043.
    PubMed    
    
    
    

66. BAHRA N, Chami Y, Bekkali R, Bennani M, et al
    Feasibility and acceptability of HPV testing using GeneXpert for cervical cancer screening in Morocco.
    Sci Rep. 2026 Apr 24. doi: 10.1038/s41598-026-46200.
    PubMed    
    
    
    

67. MENICAGLI D, Casigliani V, Panizza F, Gandolfi S, et al
    HPVoice: a single-blind three-arm RCT on social media communication strategies among adolescents in Tuscany, Italy.
    Vaccine. 2026;79:128466.
    PubMed    
    Abstract available
    
    

68. WEI T, Li Y, Zhang Z, Xu Y, et al
    Global burden, trends, and attributable risk factors of women's cancers with projection to 2050: Results from the GLOBOCAN 2022 and global burden of disease study 2021.
    Eur J Surg Oncol. 2026;52:111742.
    PubMed    
    Abstract available
    
    

69. AJROUDI OE, Razzok EM, Khadija Z, Safae H, et al
    Adherence to Human Papillomavirus Vaccination in the Province of Oujda-Angad, Morocco.
    Public Health Nurs. 2026;43:595-605.
    PubMed    
    Abstract available
    
    

70. KLEIN KV, Srivastava PV, Sauer JM, Trivedi N, et al
    The Impact of a Student-Led Initiative to Improve Cancer Screenings in Primary Care.
    Am J Prev Med. 2026;70:108262.
    PubMed    
    Abstract available
    
    

71. RYSER MD, Bravo IG, Campos NG, Hammer A, et al
    IPVS Consensus Statement on the Natural History of Cervical HPV Infection.
    J Infect Dis. 2025 Nov 14:jiaf574. doi: 10.1093.
    PubMed    
    Abstract available
    
    

72. GIGI AL, Vanslembrouck R, Bonne L, Timmerman D, et al
    Technical results and clinical outcome of transcatheter embolization for severe post-hysterectomy intra-abdominal hemorrhage.
    Rofo. 2026;198:635-643.
    PubMed    
    Abstract available
    
    

73. YANG J, Song L, Yin R, Zhong L, et al
    Cervical cancer with BRCA1 gene mutations: case reports and literature review.
    Front Oncol. 2026;16:1742990.
    PubMed    
    Abstract available
    
    

74. AKINTOLA A, Dareng EO, Adebamowo SN, Adebamowo CA, et al
    Impact of educational intervention on the uptake of self-sampling for HPV test-based cervical cancer screening.
    Front Oncol. 2026;16:1810950.
    PubMed    
    Abstract available
    
    

75. ALANAZI AM, Dardouri S
    CERV-Score: A Hybrid Machine Learning Framework for Cervical Cancer Risk Prediction Using Integrated Clinical and Genomic Data.
    Int J Telemed Appl. 2026;2026:9913421.
    PubMed    
    Abstract available
    
    

76. WENANG S, Sugiyo D, Sutantri S, Febrianti L, et al
    Population-based self-sampling under primary care conditions - a possible approach for cervical cancer screening in Indonesia (IndoCerCa study).
    Reprod Health. 2026 May 8. doi: 10.1186/s12978-026-02350.
    PubMed    
    Abstract available
    
    

77. KEBEDE HK, Gesesew HA, Mwanri L, Ward P, et al
    HIV care continuity for women in postconflict Tigray: assessing mother-to-child transmission rates, infant health and cervical cancer screening.
    BMJ Glob Health. 2026;11:e023272.
    PubMed    
    Abstract available
    
    

78. WANG JN, Liao LL, Yang F, Wang R, et al
    TSPAN8-mediated Epithelial-mesenchymal Transition Drives Acquired Radioresistance in Cervical Cancer.
    Radiat Res. 2026;205:513-527.
    PubMed    
    Abstract available
    
    

79. DUSKA LR
    Update on immune checkpoint inhibition for cervical cancer.
    Clin Adv Hematol Oncol. 2026;24:167-169.
    PubMed    
    
    
    

80. CV S, Prakash GH, B Darukaradhya T
    Cervical cancer and human papillomavirus (HPV) vaccination awareness Among university students: A global scoping review of knowledge, attitudes, and barriers.
    J Oncol Pharm Pract. 2026 May 7:10781552261446556.
    PubMed    
    Abstract available
    
    

81. GORAL S, Liljander A, Kai M, Cavalar M, et al
    High-risk and low-risk human papillomavirus detection in self-collected samples compared to clinician-collected samples in a Polish population.
    Front Public Health. 2026;14:1804719.
    PubMed    
    Abstract available
    
    

82. JI X, Ji X, Chen S, Wang X, et al
    Diagnostic accuracy of self-collected menstrual blood for high-risk human papillomavirus testing for cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis.
    Front Microbiol. 2026;17:1782917.
    PubMed    
    Abstract available
    
    

83. LAN J, Lu J, Dina T, Li Y, et al
    Akiferidin suppresses cervical cancer growth and angiogenesis via the VEGF/DLL4-Notch pathway.
    Front Pharmacol. 2026;17:1803135.
    PubMed    
    Abstract available
    
    

84. LUMIA C, Fumagalli S, Martinelli M, Ausili D, et al
    Adherence to HPV-Based Cervical Cancer Screening: A Concept Analysis for Nursing and Midwifery Practice.
    J Multidiscip Healthc. 2026;19:601358.
    PubMed    
    Abstract available
    
    

85. VAHEDPOOR Z, Matini A, Rahimi H, Lotfinia M, et al
    Expression of Programmed Death-Ligand 1 in Cervical Cancer: Correlation With Histologic Subtypes and Clinicopathological Features.
    Immun Inflamm Dis. 2026;14:e70464.
    PubMed    
    Abstract available
    
    

86. ODEI-MENSAH B, Adeyemi SA, Ngema LM, Mndlovu H, et al
    Nano-enabled targeted transdermal therapy for pain management in cervical cancer.
    J Pharm Sci. 2026 May 4:104313. doi: 10.1016/j.xphs.2026.104313.
    PubMed    
    Abstract available
    
    

87. DEBANTH A, Achary T, Halder P, Dasgupta A, et al
    Time to treatment initiation delays in cervical cancer worldwide: A systematic review and meta-analysis.
    Cancer Epidemiol. 2026;103:103095.
    PubMed    
    Abstract available
    
    

88. CHAUHAN NK, Kumar A, Jain A, Singh K, et al
    Optimizing cervical cancer diagnosis with a hybrid deep neural network and progressive resizing on pap smear WSIs.
    Sci Rep. 2026 May 6. doi: 10.1038/s41598-026-49654.
    PubMed    
    Abstract available
    
    

89. PEREZ-SANTOME I, Morales-Bravo SJ, Dominguez-Canto T
    [Risk factors for cervical intraepithelial lesions among beneficiaries of second-level care].
    Rev Med Inst Mex Seguro Soc. 2026;64:e6792.
    PubMed    
    Abstract available
    
    

90. MCNICHOLAS C, Memmel L, Kaplan C, Hwang Y, et al
    Addressing Cervical Cancer Screening Disparities: At-Home Self-Collection Among LGBQ+ Populations.
    Cancer Control. 2026;33:10732748261448263.
    PubMed    
    Abstract available
    
    

91. HARPER DM, Young AP
    Cervical cancer screening intervals extendable to ten years for 9v HPV vaccinated persons.
    Lancet Reg Health Am. 2026;58:101486.
    PubMed    
    
    
    

92. MOHAMED YB, Karimi SM
    A comprehensive review of HPV vaccination policies in the United States.
    Front Public Health. 2026;14:1810845.
    PubMed    
    Abstract available
    
    

93. ZHOU Y, Liu H, Pan S, Ruan L, et al
    Simvastatin Restores Cisplatin Sensitivity by Suppressing the Caveolin-1-Mediated PI3K/AKT Signaling Pathway in Cisplatin-Resistant Cervical Cancer Cells.
    FASEB J. 2026;40:e71873.
    PubMed    
    Abstract available
    
    

94. THAYER-FREEMAN C, Washington B, Cheek D, Luo W, et al
    Impact of variation in the alpha/beta of cervical cancer on predicted clinical outcomes.
    J Appl Clin Med Phys. 2026;27:e70608.
    PubMed    
    Abstract available
    
    

95. CHEPKORIR J, Kim T, Zamora M, Han HR, et al
    Patient portal notifications for breast and cervical cancer screening results: Perspectives of women with limited english proficiency.
    Patient Educ Couns. 2026;149:109651.
    PubMed    
    Abstract available
    
    

96. SHARMA J, Yennapu M, Kumar V
    Implementation Barriers to Cervical Cancer Screening Program in Primary Health Facilities of South Delhi: A Qualitative Inquiry.
    Indian J Public Health. 2026 Apr 18. doi: 10.4103.
    PubMed    
    Abstract available
    
    

97. TODSAPORN D, Sanachai K, Suddee N, Kanjanapanyakom C, et al
    Integrating QSAR-Machine Learning, Biochemical Assays, and Molecular Dynamics for the Discovery of JAK2 Inhibitors in Cervical Cancer.
    J Chem Inf Model. 2026 May 5. doi: 10.1021/acs.jcim.6c00414.
    PubMed    
    Abstract available
    
    

98. PAOLINO M, Basu P, Lucas E, Cucchiaro M, et al
    Barriers and Facilitators of Programmatic HPV Testing: Lessons Learnt From Two In-Depth Provincial Case Studies Ten Years After the Jujuy Demonstration Project in Argentina.
    Cancer Control. 2026;33:10732748261446046.
    PubMed    
    Abstract available
    
    

99. B VS, Prabhu A, Koumar RC
    Splicing: A New Dimension in Decoding the Complex Traits for Cervical Cancer.
    Curr Cancer Drug Targets. 2026 Apr 27. doi: 10.2174/0115680096409242251125093718
    PubMed    
    Abstract available
    
    

100. USSO AA, Mohammed H, Ahmed M
     Cervical Cancer Screening Utilization Among Female Health Workers in Ethiopia: A Systematic Review and Meta-Analysis.
     J Obstet Gynaecol Res. 2026;52:e70313.
     PubMed    
     Abstract available
     
     

101. PRABHAKARAN A, Mathias EG, Sathiyamoorthy R, Bebarta NK, et al
     Caring for the caregivers: breast and cervical cancer screening among informal caregivers of cancer patients - a scoping review.
     BMC Prim Care. 2026 May 4. doi: 10.1186/s12875-026-03333.
     PubMed    
     Abstract available
     
     

102. SHI Y, Zhang Z, Liu J, Zhu C, et al
     RILPL2 suppresses metabolic reprogramming and progression of cervical cancer by attenuating LDHA protein stability and inhibiting H3K18 lactylation.
     Cell Death Dis. 2026 May 4. doi: 10.1038/s41419-026-08808.
     PubMed    
     Abstract available
     
     

103. MARTINEZ MONTANEZ OG, Pico-Guzman FJ, Zavaleta GG, Tinoco Vazquez HR, et al
     The cost-saving impact of human papillomavirus self-sampling for cervical cancer screening in women workers at the manufacturing sector in Ciudad Juarez, Chihuahua, Mexico.
     PLOS Glob Public Health. 2026;6:e0006389.
     PubMed    
     Abstract available
     
     

104. YAN Y, Guan S, Chen W, Shi J, et al
     Trends, disparities, and multilevel interventions: A global review of HPV vaccination among university students.
     Hum Vaccin Immunother. 2026;22:2667395.
     PubMed    
     Abstract available
     
     

105. CHI C, Xu M, Zhang J, Zhang Y, et al
     CAF-Secreted Exosomes Deliver BMP4 to Confer Radiotherapy Resistance in Cervical Cancer Through a Novel Mechanism Linking Nrf2 Activation to Cuproptosis Inhibition.
     FASEB J. 2026;40:e71838.
     PubMed    
     Abstract available
     
     

106. LIANG C, Li M, Wang H, He T, et al
     Lower Limb Nonvisualization Caused by Macroarterial Thrombosis After Cervical Cancer TP Chemotherapy in Whole-body Bone Scintigraphy.
     Clin Nucl Med. 2026;51:497-499.
     PubMed    
     Abstract available
     
     

107. RAMSEYER TG, Batson B, Wu D, Matsko JL, et al
     Pap testing and high-risk HPV testing for women aged 65 years and older with surgical pathology follow-up.
     Cancer Cytopathol. 2026;134:e70111.
     PubMed    
     Abstract available
     
     

108. WANG X, Zhang Y, Wang C, Huang L, et al
     Efficacy and safety of first-line therapies for persistent, recurrent, or metastatic cervical cancer: a systematic review and exploratory network meta-analysis of immunotherapy.
     Front Immunol. 2026;17:1789532.
     PubMed    
     Abstract available
     
     

109. CORN E, Becht K, Adefres B, Monare B, et al
     The challenges of implementing less invasive surgical management for cervical cancer in a limited-resource setting in Botswana: A case series.
     Gynecol Oncol Rep. 2026;65:102089.
     PubMed    
     Abstract available
     
     

110. ISMAIL F, Zakaria Y, Md Isa ML, Nik Hassan NF, et al
     SF1, a Standardised Fraction from Clinacanthus nutans Modulates Notch1 Signalling in Cervical Cancer Stem-Like Cells.
     Malays J Med Sci. 2025;32:38-50.
     PubMed    
     Abstract available
     
     

111. BAI J, Huang J, Zhang Q, Su W, et al
     Preparation of PSA-DOX/ICG-Lip and Evaluation of Its Efficacy Against Cervical Cancer.
     Pharmaceutics. 2026;18:434.
     PubMed    
     Abstract available
     
     

112. SOZEN I, Sahin G, Ulu Y, Yitiz D, et al
     Cytology-Biopsy Concordance in High-Risk Human Papillomavirus-Positive Women with Abnormal Cytology Findings: Menopause-Stratified Analysis.
     Medicina (Kaunas). 2026;62:631.
     PubMed    
     Abstract available
     
     

113. BOLARINWA O, Bashir SG, Okyere J, Abdi YH, et al
     Burden, Regional Trends and Risk Factors of Breast, Cervical, Uterine, and Ovarian Cancers in Sub-Saharan Africa, 1990-2023: The Global Burden of Disease 2023.
     Int J Environ Res Public Health. 2026;23:419.
     PubMed    
     Abstract available
     
     

114. THAIJIAM C, Navaitthiporn N, Rithcharung P, Piyawattanametha N, et al
     Development of a Telehealth-Enabled Portable Optical Endomicroscopy System with Targeted Peptides: A Preclinical Feasibility Study for Cervical Cancer Detection.
     Cancers (Basel). 2026;18:1306.
     PubMed    
     Abstract available
     
     

115. LUCA DC, Cirimbei C, Ionescu SO, Rotaru V, et al
     Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Review.
     Diagnostics (Basel). 2026;16:1224.
     PubMed    
     Abstract available
     
     

116. BRISSON M, Drolet M, Gingras G, Laprise JF, et al
     Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study.
     Lancet. 2026;407:1726-1737.
     PubMed    
     Abstract available
     
     

117. CLIFFORD GM
     HPV vaccine scale-up is key to curb rising cervical cancer inequalities.
     Lancet. 2026;407:1662-1663.
     PubMed    
     
     
     

118. LIN B, Gruschow K, Burke A, Zhou X, et al
     Supporting breast and cervical cancer screening follow-up: qualitative health plan interviews.
     BMC Health Serv Res. 2026 May 2. doi: 10.1186/s12913-026-14641.
     PubMed    
     Abstract available
     
     

119. THI NGOC TOAN A, Palmer MR, Phung TL, Nguyen PT, et al
     Trends and disparities in cervical cancer screening prevalence in Vietnam: Evidence from the 2015 and 2021 WHO STEPS surveys.
     J Cancer Policy. 2026;48:100748.
     PubMed    
     Abstract available
     
     

120. ZHOU W, Xu Q, Qiu T, Wang J, et al
     Importin-7 Facilitates Cervical Cancer Progression Through MSI2 Nuclear Import and Is Associated With MSI2-MYC-Linked Glycolytic Reprogramming.
     Transl Res. 2026 Apr 29:S1931-5244(26)00087-3. doi: 10.1016/j.trsl.2026.
     PubMed    
     Abstract available
     
     

121. SATTURWAR S, Parwani AV, Li Z
     Advances in Digital Cytopathology and Artificial Intelligence Applications.
     Adv Anat Pathol. 2026;33:190-200.
     PubMed    
     Abstract available
     
     

122. QIAN D, Zhao L, Lin F, Wang L, et al
     Oncolytic human adenovirus 5 (H101) modulates cell cycle progression in HPV16-positive tumors.
     Biochem Biophys Res Commun. 2026;818:153747.
     PubMed    
     Abstract available
     
     

123. GHASRI S, Johnson EE, Harris BM, Forsythe I, et al
     Barriers and facilitators to using self-sampled tests for the human papillomavirus (HPV): a mixed-methods study to inform a horizon scan.
     Int J Technol Assess Health Care. 2026;42:e46.
     PubMed    
     Abstract available
     
     

124. XU MA, Pant S, DiClemente RJ
     Factors affecting human papillomavirus vaccination: A review of individual, interpersonal, and structural factors affecting vaccine uptake among adolescents.
     Vaccine. 2026;81:128563.
     PubMed    
     Abstract available
     
     

125. DENG X, Zhu T, Wang Y, Hu B, et al
     Reinforcement learning-based WSI diagnostic system for cervical squamous cell carcinoma and precancerous lesions.
     J Transl Med. 2026;24:632.
     PubMed    
     Abstract available
     
     

126. SHABANI V, Reci M, Veselievska Stojkovska V
     Cervical Cytology and Age in HPV-Infected Women in North Macedonia: A Cross-Sectional Study.
     Acta Med Acad. 2026;55:21-29.
     PubMed    
     Abstract available
     
     

127. BENOIT M, Makki H, Almadin C, Lacaille J, et al
     Colposcopy Follow-up and Findings in Women with Lower-Grade Lesions on Screening Cytology Who were Eligible for Free Human Papillomavirus Vaccination.
     J Obstet Gynaecol Can. 2026;48:103267.
     PubMed    
     Abstract available
     
     

128. LEWIS JA, Foote S, Cooper E, Butterley C, et al
     Enhancing Human Papillomavirus Vaccination Uptake After Loop Electrosurgical Excision Procedure (LEEP) at Colposcopy: A Quality Improvement Study.
     J Obstet Gynaecol Can. 2026;48:103266.
     PubMed    
     Abstract available
     
     

129. RAIMUNDO GA, Batistella T, Johann Fensterseifer M, Silveira da Silva L, et al
     Injection molded multidrug intravaginal rings with antimicrobial properties for prophylaxis and cancer treatment in women's health context.
     Drug Dev Ind Pharm. 2026;52:853-865.
     PubMed    
     Abstract available
     
     

130. CHEN J, Guo Y, Tang Y, Xiao R, et al
     Clinical and Imaging Features of Gastric-Type Endocervical Adenocarcinoma: A Report of 9 Cases with Literature Review.
     J Ultrasound Med. 2026;45:1289-1296.
     PubMed    
     Abstract available
     
     

131. ZHANG H, Li J, Xu H, Zhang S, et al
     Identifying Key Epigenetic Modification-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma and Cellular Validation.
     Curr Gene Ther. 2026;26:1-13.
     PubMed    
     Abstract available
     
     

132. LIN L, Li N, Hu X, Sun J, et al
     Identification of circ_0085616 as an Upregulated and Oncogenic Circular RNA in Cervical Cancer Via the miR-503-5p-Mediated ATXN7L3 Activation.
     Cancer Biother Radiopharm. 2026;41:244-256.
     PubMed    
     Abstract available
     
     

133. MA Z, Cai Y, Zhang L, Tian C, et al
     LINC00319 Promotes Cervical Cancer Progression Via Targeting miR-147a/IGF1R Pathway.
     Cancer Biother Radiopharm. 2026;41:234-243.
     PubMed    
     Abstract available
     
     

134. KWOK C, Endrawes G, Lee CF
     Cervical Cancer Screening Beliefs Questionnaire: Development and Psychometric Assessment With Immigrants in Australia.
     West J Nurs Res. 2026 May 15:1939459261440462. doi: 10.1177/01939459261440462.
     PubMed    
     Abstract available
     
     

135. BAK P, Ciechacka M, Al-Jeabory M, Ziemianska JK, et al
     Adaptation to neoplastic disease among women diagnosed with breast cancer and cervical cancer, taking into account the type of surgical procedure and sociodemographic factors.
     Ginekol Pol. 2026;97:297-304.
     PubMed    
     Abstract available
     
     

136. YOLANDA F, Dewi TP, Nainggolan SI, Munawar M, et al
     Multi-stakeholder perspectives on cervical cancer screening implementation in Indonesia: A qualitative study of cervical screening barriers in Banda Aceh.
     Narra J. 2026;6:e3022.
     PubMed    
     Abstract available
     
     

137. WANG Y, Yue ZN, Yang H
     Impact of adjuvant therapy after radical hysterectomy for early-stage cervical cancer on mortality and recurrence: a systematic review and meta-analysis.
     Front Oncol. 2026;16:1743116.
     PubMed    
     Abstract available
     
     

138. ZHOU J, Liao JH, Su LJ, Chen Y, et al
     Informative HPV testing after conization and its impact on time-varying estimates: a GAMM-based cohort study.
     Front Public Health. 2026;14:1808122.
     PubMed    
     Abstract available
     
     

139. TRIPATHI T, Joshi U, Chaudhary A, Janjua D, et al
     Morusin Attenuates Cancer Stemness and Modulates CSC-driven Macrophage Polarization in Cervical Cancer.
     Anticancer Agents Med Chem. 2026.
     PubMed    
     Abstract available
     
     

140. ZHAO X, Chang L, Duan W, Liu L, et al
     HPV E6/E7 mRNA vs. HPV DNA in co-testing with ThinPrep cytology for cervical cancer screening: a prospective observational diagnostic accuracy study of methylation biomarkers.
     J Gynecol Oncol. 2026 Apr 22. doi: 10.3802/jgo.2026.
     PubMed    
     Abstract available
     
     

141. FODJO MT, Youmbi AK, Mayeh M, Whegang S, et al
     Modeling the impact of budget limitation on the screening and treatment pathway of HPV-induced precancerous cervical lesions.
     Math Biosci Eng. 2026;23:1501-1533.
     PubMed    
     Abstract available
     
     

142. ZHAO J, Li Z, Qiu H, Wang J, et al
     Gastric-Type Adenocarcinoma of the Uterine Cervix From 2013 to 2023: Clinical Characteristics and Outcomes.
     J Obstet Gynaecol Res. 2026;52:e70316.
     PubMed    
     Abstract available
     
     

143. ADEPOJU OE, Xu T, Ramirez-Pulido G, Angelocci T, et al
     Individual and Co-Occurring Social Needs, and Breast and Cervical Cancer Screening Among Patients in Texas Federally Qualified Health Centers.
     J Prim Care Community Health. 2026;17:21501319261448952.
     PubMed    
     Abstract available
     
     

144. MBOUMBA BOUASSA RS, Muwonga Tukisadila J, Loemba H, Belec L, et al
     Human papillomavirus viral load as promising surrogate biomarker of cervical cancer risk and clinical outcome.
     Expert Rev Mol Diagn. 2026 May 14. doi: 10.1080/14737159.2026.2675388.
     PubMed    
     Abstract available
     
     

145. WONG L, Munigala S, Banaag A, Coles C, et al
     Guideline Concordant Cervical Cancer Screening Among Active-Duty Servicewomen in the U.S. Military from 2017 to 2022.
     J Womens Health (Larchmt). 2026 May 14:15409996261443156.
     PubMed    
     Abstract available
     
     

146. CHEMA TZ, Woldetsadik ES, Zingeta GT, Bedada HF, et al
     Symptom palliation with QUADSHOT regimen for advanced cervical cancer patients in Tikur Anbessa Specialised Hospital: a prospective cohort study.
     Ecancermedicalscience. 2026;20:2085.
     PubMed    
     Abstract available
     
     

147. GUZELBAG B, Uzuner EG, Selcuk M, Ermin S, et al
     Twelve-year trends in cervical cytology screening: a retrospective analysis of 83,148 smears from a Turkish tertiary care center.
     Front Public Health. 2026;14:1818289.
     PubMed    
     Abstract available
     
     

148. WANG Z, Zhang W, Meng X, Liang Y, et al
     Test-time adaptation-driven patient-specific auto-segmentation for CBCT-guided online adaptive radiotherapy in cervical cancer.
     J Appl Clin Med Phys. 2026;27:e70609.
     PubMed    
     Abstract available
     
     

149. BRUNISSEN L, Diwan NM, Kocher EL, Suvada K, et al
     Provider attitudes and organizational support for cervical cancer screening implementation across PEPFAR-supported HIV clinics in Kenya.
     Implement Sci Commun. 2026 May 13. doi: 10.1186/s43058-026-00958.
     PubMed    
     Abstract available
     
     

150. ABDELHAY EH, Elgamily KM, Badr WOE
     Metaheuristic optimization of deep CNNs for multi-class diagnosis of cervical cancer and lymphoma.
     Sci Rep. 2026;16:15110.
     PubMed    
     Abstract available
     
     

151. DEL REAL-ORDONEZ S, Reynoso-Noveron N, Perez-Montiel MD, Salcedo-Hernandez RA, et al
     [Sensitivity and validity of sentinel node biopsy in early-stage cervical cancer at an oncology institution].
     Cir Cir. 2026 May 13. doi: 10.24875/CIRU.24000532.
     PubMed    
     Abstract available
     
     

152. LIAN X, Qi H, Lin D, Wu Q, et al
     Real-world efficacy, safety, and associated biomarkers of cadonilimab in cervical cancer: a prospective observational study.
     Front Immunol. 2026;17:1723923.
     PubMed    
     Abstract available
     
     

153. KAUL IK, Garber BL, Koch TL, Altomare AL, et al
     Understanding Barriers to Cervical Cancer Screening: A Quality Improvement Project in the HIV Clinics at Dartmouth Health.
     AJPM Focus. 2026;5:100488.
     PubMed    
     Abstract available
     
     

154. TEJADA R, Baena A, Trujillo L, Rodriguez J, et al
     Impact of switching from a quadrivalent to a nonavalent HPV vaccine on HPV infections and cervical cancer in Colombia: a mathematical modelling study.
     Lancet Reg Health Am. 2026;58:101483.
     PubMed    
     Abstract available
     
     

155. AGRAWAL A, Archana, Shakya P, Verma U, et al
     Evaluation of Different Diagnostic Modalities for Screening and Molecular Characterization of Human Papillomavirus Causing Cervical Cancer.
     J Midlife Health. 2026;17:111-116.
     PubMed    
     Abstract available
     
     

156. XI M, Ao M, Li J, Zhang S, et al
     Risk of High-Grade Cervical Intraepithelial Neoplasia Using human Papillomavirus Extended Genotyping in Chinese Women With Normal Cervical Cytology: A Population-Based Screening Cohort.
     J Med Virol. 2026;98:e70968.
     PubMed    
     Abstract available
     
     

157. MASOUD M, Shastri C, Banerjee R, Dasgupta S, et al
     Genome-Wide DNA Methylation Profiling Reveals Ancestry-Associated Epigenetic Reprogramming in Cervical Intraepithelial Neoplasia.
     Int J Mol Sci. 2026;27:3986.
     PubMed    
     Abstract available
     
     

158. GREEGRAINUCH K, Kansandee W, Pientong C, Ekalaksananan T, et al
     Antiviral and Anticancer Activities of Stingless Bee Propolis from Tetragonula drescheri and Tetragonula pagdeni: Toward Development of Prototype Healthcare Pharmaceuticals.
     Int J Mol Sci. 2026;27:3855.
     PubMed    
     Abstract available
     
     

159. YIN L, Lv F
     Ultrasound-Clinical Machine Learning Models for Differentiating Early Cervical Cancer from Myoma: A Retrospective Exploratory Study.
     J Clin Med. 2026;15:3300.
     PubMed    
     Abstract available
     
     

160. JURCZAK M, Charzewski L, Gozlinska B, Albrycht P, et al
     Artificial Intelligence-Assisted Colposcopy: Deep Learning Multi-Class Segmentation of Anatomical Structures and Pathological Findings for Cervical Cancer Screening.
     Cancers (Basel). 2026;18:1485.
     PubMed    
     Abstract available
     
     

161. TIAN D, Du M, Zheng Z, Wang W, et al
     NSUN4 Suppresses Ferroptosis Through m(5)C-Dependent Stabilization of C-MYC and Activation of the PI3K/Akt Signaling Pathway in Cervical Cancer.
     Cancers (Basel). 2026;18:1392.
     PubMed    
     Abstract available
     
     

162. TAMENANG A, Vohl V, Schwartz C, Kropidlowski J, et al
     Circulating microRNA Profiles as Diagnostic Tools for High-Grade Cervical Lesions and HPV Genotype Stratification.
     Cells. 2026;15:849.
     PubMed    
     Abstract available
     
     

163. PAHRIA T, Haroen H, Agustina HR, Sari CWM, et al
     Women's experiences toward cervical cancer care at the initiation of care: a qualitative study closing the gap policy and implementation in Indonesia.
     BMC Womens Health. 2026 May 13. doi: 10.1186/s12905-026-04493.
     PubMed    
     Abstract available
     
     

164. KULKARNI V, Jaiswal A, Kshirsagar N, Arya M, et al
     Accelerated MRI-Guided Brachytherapy in Cervical Cancer.
     Clin Oncol (R Coll Radiol). 2026;55:104172.
     PubMed    
     
     
     

165. KANG Y, Zhuang L, Chang L, Liu J, et al
     The Prognosis of Patients With Large Cell Carcinoma of the Cervix: A Retrospective Study of the SEER Database and a Chinese Multi-Center Registry.
     Cancer Control. 2026;33:10732748261449853.
     PubMed    
     Abstract available
     
     

166. LI J, Wang Y, Xu Z, Ao S, et al
     Comparative analysis of cervical cancer burden trends between China and G20 countries from 1990 to 2023 with projections to 2035: A population-based observational study.
     Medicine (Baltimore). 2026;105:e48640.
     PubMed    
     Abstract available
     
     

167. LIU H, Huang F, Da H, Yin Q, et al
     Absence of causal association between CD40-CD40L signaling and cervical cancer risk: A Mendelian randomization study.
     Medicine (Baltimore). 2026;105:e48638.
     PubMed    
     Abstract available
     
     

168. YU H, Liang H, Liang X, Lin H, et al
     The influence of robotic-assisted systems on the surgical approach and outcomes in hysterectomy for benign and malignant diseases.
     J Robot Surg. 2026;20:484.
     PubMed    
     Abstract available
     
     

169. GARG P, Kumar P, Gupta M, Bindal P, et al
     Determinants of cervical cancer screening and HPV vaccination among female medical practitioners in Punjab, India.
     Sci Rep. 2026 May 11. doi: 10.1038/s41598-026-52609.
     PubMed    
     Abstract available
     
     

170. HAN Y, Wang C, Wang X, Sun S, et al
     Clinical Implementation of Dual-Isocenter MR-Guided Radiotherapy for Large-Target Cervical Cancer: A Dosimetric and Workflow Analysis.
     Pract Radiat Oncol. 2026 May 9:S1879-8500(26)00144.
     PubMed    
     Abstract available
     
     

171. XIE T, He Y, Tan M, Gao Y, et al
     Caprin-1 silencing reverses YY1/HSP90alpha-mediated IDH1 stabilization to induce ferroptosis and sensitize cervical cancer to cisplatin.
     Cell Signal. 2026;145:112584.
     PubMed    
     Abstract available
     
     

172. QI L, Zhu D, Qian L, Yi B, et al
     SIRT1-mediated deacetylation stabilizes cortactin to enhance glycolysis and drive cervical cancer progression.
     Cell Signal. 2026 May 9:112587. doi: 10.1016/j.cellsig.2026.112587.
     PubMed    
     Abstract available
     
     

173. DE OLIVEIRA HF, de Souza FD
     Comment on: "The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer".
     Clinics (Sao Paulo). 2026;81:100953.
     PubMed    
     
     
     

174. SIDONIE M, Elisabete G
     Oncologic, pregnancy, and reproductive outcomes of fertility-sparing surgery in early-stage cervical cancer: a systematic review.
     Surg Oncol. 2026;66:102439.
     PubMed    
     Abstract available
     
     

175. HOLT HK, Ransohoff AK, Sawaya GF
     Self-Collected HPV Testing for Cervical Cancer Screening-Responsible Implementation to Reduce Disparities.
     JAMA Intern Med. 2026 May 11. doi: 10.1001/jamainternmed.2026.1212.
     PubMed    
     
     
     

176. RAHAVI H, Najafi A, Asgarian-Omran H, Aflatoonian B, et al
     Dual Blockade of PD-L1 and AXL: A Novel Immunotherapeutic Approach for Ovarian and Cervical Cancer.
     Iran J Allergy Asthma Immunol. 2026;25:234-250.
     PubMed    
     Abstract available
     
     

177. SACHIT BA, Dass S, Rajan RS, Tye GJ, et al
     Integrated in silico-in vitro identification of high-affinity TCR-Like antibodies targeting HPV18 E6/E7 for cervical cancer detection.
     Arch Virol. 2026;171:177.
     PubMed    
     Abstract available
     
     

178. LIN J, He H, Liu B, He T, et al
     The exploration of iparomlimab and tuvonralimab combined with de-escalated chemotherapy as an innovative neoadjuvant treatment strategy for locally advanced cervical cancer: a case report from the NICE-CC trial.
     Front Immunol. 2026;17:1801164.
     PubMed    
     Abstract available
     
     

179. ZHANG Y, Xing W, Liang X, Ma Y, et al
     A retrospective analysis of the prognostic value of nutritional-inflammatory markers for patients with cervical cancer.
     PeerJ. 2026;14:e21273.
     PubMed    
     Abstract available
     
     

180. SOUSA R, Fonseca-Moutinho JA, Gomes F, Loureiro F, et al
     Impact of the transition to HPV-based primary screening in Portugal's organized cervical cancer screening program: A controlled interrupted time-series analysis (2014-2023).
     Public Health Pract (Oxf). 2026;11:100792.
     PubMed    
     Abstract available
     
     

181. NDAKUKAMO EK, Mahalie R, Hailonga-Van Dijk P
     Health-seeking behaviour of rural women regarding cervical cancer prevention in Namibia: A qualitative study.
     J Public Health Afr. 2026;17:1632.
     PubMed    
     Abstract available
     
     

182. 
     MiR-155-5p Accelerates the Metastasis of Cervical Cancer Cell via Targeting TP53INP1 [Retraction].
     Onco Targets Ther. 2026;19:620871.
     PubMed    
     Abstract available
     
     

183. XU S, Li Y, Yi X, Yan Z, et al
     Nationwide epidemiology of HPV E6/E7 mRNA in China: genotype distribution in 11,118 women.
     Front Public Health. 2026;14:1797051.
     PubMed    
     Abstract available
     
     

184. WAN M, Zhong T, Shi W, Shen J, et al
     PRDM1 Is Associated with Chemoradiotherapy-Associated Enrichment of Adaptive NK Cells in Cervical Cancer.
     Comput Struct Biotechnol J. 2026;35:0092.
     PubMed    
     Abstract available
     
     

185. WANG X, Xiong D, Cui S, Duan B, et al
     Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends, 2015-2024.
     Front Oncol. 2026;16:1732209.
     PubMed    
     Abstract available
     
     

186. XIAO H, Qu A, Sun H, Zhang X, et al
     Dosimetric impact of two multileaf collimator systems in simultaneous integrated boost volumetric modulated arc therapy for lymph node metastases in stage IIIC cervical cancer.
     Front Oncol. 2026;16:1805020.
     PubMed    
     Abstract available
     
     

187. LOSHNI V, Lakshmi T, Balaji R
     GC?MS analysis, molecular docking, molecular dynamics simulation, and pharmacokinetic profiling of bioactive compounds from Terminalia bellirica seeds against cervical cancer targets.
     In Silico Pharmacol. 2026;14:136.
     PubMed    
     Abstract available
     
     

188. LEE KH, Jeong JH, Park CJ, Kim YS, et al
     Extensive Grouped Papules on the Vulva in a Patient with Cervical Cancer.
     Indian J Dermatol. 2026;71:256.
     PubMed    
     
     
     

189. MATSUNAGA A, Ogawa M, Kunita A, Ikeda Y, et al
     Type-specific detection and quantification of circulating tumor HPV DNA by digital PCR in surgically resected cervical cancer.
     J Gynecol Oncol. 2026 Apr 22. doi: 10.3802/jgo.2026.
     PubMed    
     Abstract available
     
     

190. COMMEH ME, Husain N, Afrane CB, Apatu M, et al
     Partnership Driving Impact: An Integrated Women-Centric Model to Improve Early Detection and Treatment of Cervical and Breast Cancer in Ghana and India.
     Cancer Med. 2026;15:e71890.
     PubMed    
     Abstract available
     
     

191. RIGGENBACH E, Tadic T, Han K
     Uterine ultra-mover in cervical cancer radiotherapy: retroversion and the rationale for online adaptive planning.
     Pract Radiat Oncol. 2026 May 8:S1879-8500(26)00137.
     PubMed    
     
     
     

192. BAHRUN, Melanie H, Artanti N, Anita Y, et al
     Integrated In vitro, network pharmacology, and In silico analysis reveal the anti-cervical cancer properties of calcareous green algae Halimeda sp.
     Comput Biol Chem. 2026;124.
     PubMed    
     Abstract available
     
     

193. HELLSTEN C, Magnusson L, Borgfeldt C
     Women's reasoning and experience in the cervical cancer screening programme when offered a self-sampling HPV test: a qualitative content analysis.
     BMC Womens Health. 2026;26:239.
     PubMed    
     Abstract available
     
     

194. PAKONEN J, Jensen A, Cruz Zorrilla M, Gutierrez R, et al
     Beyond Free Screening: Structural Barriers to Follow-Up Cervical Cancer Care Among Uninsured Hispanic Women in Minnesota, 2020-2021.
     Public Health Rep. 2026 May 9:333549261442167. doi: 10.1177/00333549261442167.
     PubMed    
     Abstract available
     
     

195. HABIBA U, Ayaz M, Islam N
     Machine Learning-driven Prediction of Cervical Cancer Cell Viability After Treatment With Thymoquinone, Curcumin, and 5-Fluorouracil.
     Appl Biochem Biotechnol. 2026 May 9. doi: 10.1007/s12010-026-05704.
     PubMed    
     Abstract available
     
     

196. ARNO A, Pernazza A, Leopizzi M, Benedettucci E, et al
     Clinical relevance and prognostic role of PDL-1 expression in cervical cancer patients.
     Arch Gynecol Obstet. 2026;313:193.
     PubMed    
     
     
     

197. SOYLER S, Sipahi BB, Cavmak D
     Exploring barriers to women's participation in breast and cervical cancer screening programs: insights from national health surveys in Turkiye.
     BMC Health Serv Res. 2026 May 7. doi: 10.1186/s12913-026-14656.
     PubMed    
     Abstract available
     
     

198. KUMAR M, Barmon D, Baruah U, Begum D, et al
     Disease laterality independently predicts survival in stage IIIB cervical cancer in a prospective cohort study from Northeast India.
     Sci Rep. 2026 May 8. doi: 10.1038/s41598-026-48514.
     PubMed    
     Abstract available
     
     

199. 
     Corrigendum to "A Novel Network-Level Fused Self-Attention Deep Neural Network for Cervical Cancer Classification from Cervicography Images".
     Technol Cancer Res Treat. 2026;25:15330338261451109.
     PubMed    
     
     
     

200. ZELEKE AJ, Reifferscheid L, Yunusa U, Gandhi K, et al
     Population-level impact of HPV vaccination: a global systematic review of ecological, cross-sectional, and cohort studies.
     Expert Rev Vaccines. 2026;25:2667734.
     PubMed    
     Abstract available
     
     

201. LIN S, Luo Z, Li Y, Hu B, et al
     Integrated spatial multi-omics delineates fatty acid degradation fuels malignant evolution at the tumour periphery in cervical squamous cell carcinoma.
     EBioMedicine. 2026;127:106256.
     PubMed    
     Abstract available
     
     

202. BENDARI A, Ahsan BU, Mohammed H, Al-Refai R, et al
     Clinicopathologic Features of Six Patients With Metastatic Carcinoma to the Uterine Cervix.
     Int J Surg Pathol. 2026;34:997-1006.
     PubMed    
     Abstract available
     
     

203. PEREZ AN, Curry JL, Madewell JE, Meis JM, et al
     Florid Pseudosarcomatous Polypoid Fibroplasia: An Unusual Cutaneous Manifestation of Chronic Lymphedema.
     Int J Surg Pathol. 2026;34:970-975.
     PubMed    
     Abstract available
     
     

204. SAUNDERS T, Boyd L, Machado Colling A, He J, et al
     Nurse Roles Implementing the Choice for Self-Collection Cervical Screening in Rural Settings: A Qualitative Study Following National Policy Change.
     J Adv Nurs. 2026;82:6543-6556.
     PubMed    
     Abstract available
     
     

205. HALM EA, Del Vecchio NJ, Rendle KA, Tiro JA, et al
     Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium.
     J Gen Intern Med. 2026;41:1761-1770.
     PubMed    
     Abstract available
     
     

206. THOMPSON EL, Griner SB, Akpan IN, Maness SB, et al
     HPV Vaccination Knowledge, Attitudes, and Behaviors Among Clinic Teams in North Texas.
     J Cancer Educ. 2026;41:296-301.
     PubMed    
     Abstract available
     
     

207. MINAMITANI M, Katano A, Ohira S, Hayashi T, et al
     Evaluating Behavioral Impacts of School Cancer Education Programs Several Months and Years After Implementation in Japan.
     J Cancer Educ. 2026;41:270-276.
     PubMed    
     Abstract available
     
     

208. JORGENSEN SF, Nielsen ML, Njor SH
     Adherence to recommended follow-up in opportunistic versus non-opportunistic cervical screening: a registry-based cohort study from Denmark.
     Scand J Public Health. 2026;54:297-306.
     PubMed    
     Abstract available
     
     

209. ALAREF G, Petersen LK
     Accuracy of human papillomavirus testing in detecting persistent or recurrent disease at follow-up after conization.
     Acta Obstet Gynecol Scand. 2026;105:960-968.
     PubMed    
     Abstract available
     
     

210. LAWRENCE L
     HRSA recommends offering self-collection for cervical cancer screening.
     Cancer. 2026;132:e70369.
     PubMed    
     
     
     

211. OSAWA N, Chikazawa K, Ko H, Kuwata T, et al
     Follow-up by resident physicians is associated with underuse of hormone replacement therapy after cervical cancer treatment: A retrospective study.
     Eur J Obstet Gynecol Reprod Biol. 2026;323:115170.
     PubMed    
     Abstract available
     
     

212. BORKAR SR, Tasman JG, Bakkum-Gamez JN, Cheney MC, et al
     Exploring delays in primary gynecologic and breast cancer diagnosis after emergency department presentation.
     Gynecol Oncol. 2026;208:41-47.
     PubMed    
     Abstract available
     
     

213. WATCHARASIN P, Sirimusika N, Atjimakul T, Rattanaburi A, et al
     Diagnostic performance of human papillomavirus DNA cycle threshold values in the detection of high-grade cervical intraepithelial neoplasia.
     Int J Gynaecol Obstet. 2026;173:1617-1627.
     PubMed    
     Abstract available
     
     

214. WANG XS, Pond GR, Piedimonte S, Nelson G, et al
     Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study.
     Int J Gynecol Cancer. 2026;36:104695.
     PubMed    
     Abstract available
     
     

215. LIM H, Lee C, Back JW, Seol A, et al
     Association of primary treatment modality and programmed death-ligand 1 expression with survival outcomes in locally advanced human papillomavirus-independent endocervical adenocarcinoma.
     Int J Gynecol Cancer. 2026;36:104652.
     PubMed    
     Abstract available
     
     

216. KOBAYASHI M, Nakagawa S, Matsuzaki S, Ouzounian AJ, et al
     Treatment modality-specific survival of small cell neuroendocrine carcinoma of the uterine cervix with T1b3-2b classifications.
     Int J Gynecol Cancer. 2026;36:104644.
     PubMed    
     Abstract available
     
     

217. CHEN Z, Zeng Y, Luo L, Li J, et al
     Multi-center-validated machine learning model for cervical cancer based on human papillomavirus genotyping results.
     Int J Gynecol Cancer. 2025;36:102855.
     PubMed    
     Abstract available
     
     

218. SAINI SK, Srivastava S, Goel A, Sharma DN, et al
     Outcomes of Stage IVA Cervical Cancer Treated with Radiotherapy: A Systematic Review and Meta-Analysis.
     Int J Radiat Oncol Biol Phys. 2026 Apr 23:S0360-3016(26)00571.
     PubMed    
     Abstract available
     
     

219. CLARK M, Rusley J, Graham C, Cronin B, et al
     Self-Sampling for Cervical Cancer Screening in Transmasculine and Nonbinary People.
     Obstet Gynecol. 2026 Apr 30. doi: 10.1097/AOG.0000000000006296.
     PubMed    
     Abstract available
     
     

220. LEUNG RC, Liu SS, Chan KY, Tam KF, et al
     [Expression of Concern] Promoter methylation of death?associated protein kinase and its role in irradiation response in cervical cancer.
     Oncol Rep. 2026;55:120.
     PubMed    
     Abstract available
     
     

221. ASSEFA KT, Worku AG, Muche AA, Geremew BM, et al
     Geographic inequities in human papillomavirus vaccine non-uptake and its determinants among adolescent girls in Ethiopia: Evidence from the National Immunization Survey.
     PLoS One. 2026;21:e0348076.
     PubMed    
     Abstract available
     
     

222. BITEWA MD, Yewodiaw TK, Abneh AA, Molla MG, et al
     Determinants of cervical cancer screening among women aged 30 to 49 years in 20 low- and middle-income countries: A multilevel analysis.
     PLoS One. 2026;21:e0347837.
     PubMed    
     Abstract available
     
     

223. TILAHUN SW, Nega A, Wagaw L, Addissie A, et al
     Shared decision-making in Cervical Cancer Care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A mixed-methods study.
     PLoS One. 2026;21:e0348172.
     PubMed    
     Abstract available
     
     

224. ESSAYAGH T, Essayagh M, Nmila K, Slibani H, et al
     Prevalence and determinants of parental refusal of human papillomavirus vaccination in Morocco: A multicenter cross-sectional study.
     PLoS One. 2026;21:e0348586.
     PubMed    
     Abstract available